Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Skystar Bio-Pharmaceutical Company Lowers FY 2011 Revenue Guidance
CreateTime:2011-08-23     Source:Reuters Editor:hangmei
Text Size:       

Monday, 22 Aug 2011 05:38pm EDT
Skystar Bio-Pharmaceutical Company (SKBI.NSDQ)announced that for fiscal 2011, it expects revenue guidance to be in the range of $52 million to $55 million.

Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1